LOS ANGELES (KABC) -- Proton therapy to treat prostate cancer has been available in Southern California for nearly 35 years. It's less invasive and offers fewer side effects compared to conventional ...
Of the 300 patients in the PARCER trial, 93 faced grades ≥2 adverse events (3D-CRT = 59, IG-IMRT = 34). Patients in the 3D-CRT and IG-IMRT arms spent an average of 2.39 years and 1.96 years in ...
Please provide your email address to receive an email when new articles are posted on . Patients receiving remote radiation oncology care reported high levels of satisfaction. Individuals who had ...
The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little ...
Targeting glioma stem cells with thyroid hormone suppression: Phase 1/2 trial of methimazole in patients with progressive grade 4 gliomas. Phase 1 study of anti–immunoglobulin-like transcript 3 (ILT3) ...
Medicare covers screenings and treatment for prostate cancer, with Part A covering hospital care and Part B covering outpatient care and outpatient cancer medications. Original Medicare (parts A and B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results